A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index.

A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index.

BACKGROUND: There is little consensus on a standard approach to analysing bone scan images. The Bone Scan Index (BSI) is predictive of survival in patients with progressive prostate cancer (PCa), but the popularity of this metric is hampered by the tedium of the manual calculation. OBJECTIVE: Develo...

Полное описание

Библиографические подробности
Главные авторы:	Ulmert, D, Kaboteh, R, Fox, J, Savage, C, Evans, M, Lilja, H, Abrahamsson, P, Björk, T, Gerdtsson, A, Bjartell, A, Gjertsson, P, Höglund, P, Lomsky, M, Ohlsson, M, Richter, J, Sadik, M, Morris, M, Scher, H, Sjöstrand, K, Yu, A, Suurküla, M, Edenbrandt, L, Larson, S
Формат:	Journal article
Язык:	English
Опубликовано:	2012

Схожие документы

Prostate kallikrein markers in diagnosis, risk stratification and prognosis.
по: Ulmert, D, и др.
Опубликовано: (2009)

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.
по: Vickers, A, и др.
Опубликовано: (2010)

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: Case-control study
по: Vickers, A, и др.
Опубликовано: (2010)

Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.
по: Lilja, H, и др.
Опубликовано: (2007)

A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening.
по: Vickers, A, и др.
Опубликовано: (2011)

Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.
по: Ulmert, D, и др.
Опубликовано: (2012)

Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.
по: Klein, R, и др.
Опубликовано: (2012)

Empirical estimates of the lead time distribution for prostate cancer based on two independent representative cohorts of men not subject to prostate-specific antigen screening.
по: Savage, C, и др.
Опубликовано: (2010)

A prospective study to evaluate the intra-individual reproducibility of bone scans for quantitative assessment in patients with metastatic prostate cancer
по: Mariana Reza, и др.
Опубликовано: (2018-05-01)

Rapid elimination by glomerular filtration of free prostate specific antigen and human kallikrein 2 after renal transplantation.
по: Bruun, L, и др.
Опубликовано: (2004)

The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: towards a biologically-based screening strategy.
по: Vickers, A, и др.
Опубликовано: (2007)

Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50.
по: Lilja, H, и др.
Опубликовано: (2011)

Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses.
по: Ulmert, D, и др.
Опубликовано: (2012)

Editorial Comment
по: Ulmert, D, и др.
Опубликовано: (2008)

miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
по: Hagman, Z, и др.
Опубликовано: (2010)

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.
по: Lilja, H, и др.
Опубликовано: (2008)

Prostate-specific antigen and prostate cancer: Prediction, detection and monitoring (Corrigendum) (Nature Reviews Cancer (2008) 8, (268-278))
по: Lilja, H, и др.
Опубликовано: (2008)

Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study.
по: Ulmert, D, и др.
Опубликовано: (2008)

Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
по: Ulmert, D, и др.
Опубликовано: (2008)

Tumor markers in prostate cancer I: blood-based markers.
по: Shariat, S, и др.
Опубликовано: (2011)

A simple statistical model for prediction of acute coronary syndrome in chest pain patients in the emergency department
по: Edenbrandt Lars, и др.
Опубликовано: (2006-07-01)

Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C.
по: Ulmert, D, и др.
Опубликовано: (2006)

Small average differences in attenuation corrected images between men and women in myocardial perfusion scintigraphy: a novel normal stress database
по: Jakobsson David, и др.
Опубликовано: (2011-10-01)

3D skeletal uptake of 18F sodium fluoride in PET/CT images is associated with overall survival in patients with prostate cancer
по: Sarah Lindgren Belal, и др.
Опубликовано: (2017-02-01)

Correction to: 3D skeletal uptake of 18F sodium fluoride in PET/CT images is associated with overall survival in patients with prostate cancer
по: Sarah Lindgren Belal, и др.
Опубликовано: (2019-05-01)

Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland.
по: Bjartell, A, и др.
Опубликовано: (2006)

Detection of androgen receptor mutations in circulating tumor cells: highlights of the long road to clinical qualification.
по: Lilja, H, и др.
Опубликовано: (2010)

Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections.
по: Siivola, P, и др.
Опубликовано: (2000)

Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues.
по: Olsson, A, и др.
Опубликовано: (2005)

Time-resolved fluorescence imaging for quantitative histochemistry using lanthanide chelates in nanoparticles and conjugated to monoclonal antibodies.
по: Väisänen, V, и др.
Опубликовано: (2000)

RECOMIA—a cloud-based platform for artificial intelligence research in nuclear medicine and radiology
по: Elin Trägårdh, и др.
Опубликовано: (2020-08-01)

AI-based detection of lung lesions in [18F]FDG PET-CT from lung cancer patients
по: Pablo Borrelli, и др.
Опубликовано: (2021-03-01)

Artificial intelligence-aided CT segmentation for body composition analysis: a validation study
по: Pablo Borrelli, и др.
Опубликовано: (2021-03-01)

Analgesic and Nonanalgesic Effects of Intravenous Hydromorphone - Relation to Plasma Concentrations in Healthy Volunteers
по: D Westerling, и др.
Опубликовано: (1996-01-01)

Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancer.
по: Christensson, A, и др.
Опубликовано: (2011)

Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.
по: Evans-Axelsson, S, и др.
Опубликовано: (2012)

α2-macroglobulin and α1-inhibitor-3 mRNA expression in the rat liver after slow interleukin-1 stimulation
по: T. Gudmundsson, и др.
Опубликовано: (1996-01-01)

A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue.
по: Valtonen-André, C, и др.
Опубликовано: (2007)

Expression and immunolocalisation of neutral endopeptidase in prostate cancer.
по: Albrecht, M, и др.
Опубликовано: (2003)

AI-based fully automatic image analysis: Optimal abdominal and thoracic segmentation volumes for estimating total muscle volume on computed tomography scans
по: Thomas Ying, и др.
Опубликовано: (2024-06-01)